Melanotan II excites histaminergic neurons via MC4R, but inhibiting these neurons enhances its anorexigenic effects
Background
Histaminergic neurons in the tuberomammillary nucleus (TMN) are crucial for promoting wakefulness and regulating energy homeostasis. The melanocortin system is a key regulator of appetite and metabolism, with the melanocortin 4 receptor (MC4R) playing a central role. While evidence suggests MC4R expression in the TMN, it has been unclear whether the melanocortin system directly influences the activity of histamine-producing neurons—those expressing histidine decarboxylase (HDC). This gap in knowledge is significant because understanding this interaction could reveal new mechanisms controlling both arousal and body weight, particularly in the context of obesity, where both systems are often dysregulated.
Study Design
The study used Hdc-Cre mice to specifically target histamine-producing neurons. Researchers performed whole-cell patch-clamp electrophysiology to measure neuronal activity in brain slices. They applied melanotan II (MTII), a non-selective melanocortin receptor agonist, as well as selective agonists (THIQ, [D-Trp8]-γ-MSH) and synaptic transmission inhibitors (TTX, CNQX, AP5) to dissect the mechanism. The perifornical lateral hypothalamic area (PeFLH) was electrically stimulated to assess synaptic responses. In living mice, they used in vivo chemogenetic techniques to inhibit HDC neurons and then administered MTII intracerebroventricularly to observe the effects on appetite.
Results
Subsets of HDC-expressing neurons were directly excited by the application of melanotan II. This effect was determined to be mediated specifically by MC4Rs through a presynaptic mechanism dependent on glutamate. MTII enhanced the evoked excitatory post-synaptic currents (EPSCs) that originated from electrical stimulation of the perifornical lateral hypothalamic area (PeFLH), confirming that melanocortins act on the glutamatergic PeFLH projection to the TMN. The most striking finding came from the in vivo experiments:
Chemogenetic inhibition of
HDCneurons significantly enhanced the anorexigenic (appetite-suppressing) effects of intracerebroventricularly administered MTII.
This counterintuitive result suggests that while the melanocortin system activates these wake-promoting neurons, the downstream effect of this specific activation is to restrain or put a brake on the overall appetite suppression driven by the melanocortin system.
Key Findings
- Melanotan II (MTII), a non-selective agonist, directly excited a subset of HDC-expressing (histaminergic) neurons.
- The excitatory effect is mediated specifically by MC4R via a presynaptic, glutamatergic-dependent mechanism.
- MTII enhanced excitatory currents from the perifornical lateral hypothalamic area (PeFLH) projection to the TMN.
- In vivo chemogenetic inhibition of HDC neurons strikingly enhanced the anorexigenic effects of intracerebroventricular MTII.
- HDC neurons appear to act as a natural brake, restraining the full anorexigenic effect of melanocortin system activation.
Why It Matters
This research reveals a previously unknown feedback loop where melanocortin activation, while suppressing appetite overall, also stimulates a neural circuit that counteracts this effect. For peptide users, this implies that the anorexic effects of compounds like Melanotan II might be dampened by a natural, built-in braking system involving histamine neurons. This suggests that the full anorexic potential of MC4R agonists may be restrained by this neuronal cross-talk. This finding could have implications for developing obesity treatments; future strategies might involve co-targeting the melanocortin and histaminergic systems to achieve more potent appetite suppression. The study also highlights a complex interplay between systems controlling metabolism and arousal, which may be relevant for understanding the side effects or full efficacy of melanocortin-based therapies.
